Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

Johnsson, Anders LU ; Hagman, Helga LU ; Frödin, Jan-Erik ; Berglund, Åke ; Keldsen, N. ; Fernebro, Eva LU ; Sundberg, J ; De Pont Christensen, R ; Garm Spindler, K-L and Bergström, D , et al. (2013) In Annals of Oncology 24(9). p.2335-2341
Abstract
The main objective was to study the effect on progression-free survival (PFS) of adding erlotinib to bevacizumab as maintenance treatment following chemotherapy and bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC).
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of Oncology
volume
24
issue
9
pages
2335 - 2341
publisher
Oxford University Press
external identifiers
  • wos:000323963100020
  • pmid:23788755
  • scopus:84883339111
ISSN
1569-8041
DOI
10.1093/annonc/mdt236
language
English
LU publication?
no
id
cbc307cd-b479-4a04-bb4d-7eb9196c2887 (old id 3913091)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23788755?dopt=Abstract
date added to LUP
2016-04-01 10:21:00
date last changed
2022-02-10 01:15:36
@article{cbc307cd-b479-4a04-bb4d-7eb9196c2887,
  abstract     = {{The main objective was to study the effect on progression-free survival (PFS) of adding erlotinib to bevacizumab as maintenance treatment following chemotherapy and bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC).}},
  author       = {{Johnsson, Anders and Hagman, Helga and Frödin, Jan-Erik and Berglund, Åke and Keldsen, N. and Fernebro, Eva and Sundberg, J and De Pont Christensen, R and Garm Spindler, K-L and Bergström, D and Jakobsen, A}},
  issn         = {{1569-8041}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{2335--2341}},
  publisher    = {{Oxford University Press}},
  series       = {{Annals of Oncology}},
  title        = {{A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.}},
  url          = {{http://dx.doi.org/10.1093/annonc/mdt236}},
  doi          = {{10.1093/annonc/mdt236}},
  volume       = {{24}},
  year         = {{2013}},
}